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Abstract 
Tissue engineering is an interdisciplinary field that uses a combination of cells, suitable biomaterials and bioactive 
molecules to engineer the desired tissue and restore lost function. These principles have quickly begun to spread to the 
therapy of multiple diseases, including depigmentation disorders. The most common depigmentation disorder is vitiligo, 
a disease with deep psychosocial implications. Thanks to their unique properties, electrospun polymeric nanofibers 
represent a material suitable for tissue engineering applications. Furthermore, they may be functionalized with platelets, 
cells that contain a wide spectrum of growth factors and chemokines. The aim of this paper was to evaluate the 
functionalization of polymeric nanofibers with platelets and their effects in melanocyte culture. The scaffolds were 
visualized using scanning electron microscopy, the metabolic activity and proliferation of melanocytes was determined 
using MTS assay and dsDNA quantification, respectively. Furthermore, the melanocytes were stained and visualized 
using confocal microscopy. The acquired data showed that poly-ε-caprolactone functionalized with platelets promoted 
the viability and proliferation of melanocytes. According to the results, such a functionalized scaffold combining 
nanofibers and platelets may be suitable for melanocyte culture. 
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Introduction  
Tissue engineering is a dynamically developing 
medical field aiming to restore, maintain or improve 
the function of tissues or organs. Its principles were 
also proposed for the treatment of depigmentation 
disorders, such as vitiligo. Vitiligo is characterized by 
acquired, idiopathic and progressive skin and hair 
depigmentation resulting from loss of functional mela-
nocytes [1]. Even nowadays, vitiligo still represents 
a difficult psychosocial issue, which can lead to de-
presssion or anxiety [2, 3]. The concept of a “cellular 
patch” has been proposed [4], consisting of a suitable 
biomaterial allowing melanocyte expansion. 
Polymeric nanofibers could belong among such 
suitable biomaterials, as they have been widely used in 
other tissue engineering applications [5]. One of the 
most common nanofiber preparation techniques is 
electrospinning. Electrospinning employs electrical 
forces to draw submicron fibers from polymer solu-
tions and melts. Thanks to their unique properties, 
electrospun nanofibers have been shown to mimic the 
structure and biological function of the native extra-
cellular matrix (ECM) [6]. These properties include the 
microarchitecture of the nanofibrous mats, resembling 
the native ECM, and their high volume-to-surface ratio, 
facilitating functionalization of nanofibers with bio-
active molecules, such as growth factors and cytokines 
[7]. 
Platelets; cells involved in blood clotting, represent 
a promising and versatile source of growth factors. In 
their alpha granules, they contain supraphysiological 
levels of a variety of growth factors, chemokines and 
cytokines. These bioactive molecules include platelet-
derived growth factors (PDGF), epidermal growth 
factor (EGF), transforming growth factor-β (TGF-β), 
RANTES, monocyte chemoattractant protein-1 
(MCP-1), thrombospondin and fibrinogen [8]. 
Platelet concentrates are commonly used in trans-
fusion medicine as a hemostatic tool. The standard 
shelf-life of platelet products is 5 days; following 
that  they rapidly lose their hemostatic function [9]. 
However, it has been shown, that the platelets retain 
their proliferation potential for up to 21 days [10]. 
Given the fact that the shelf-life of growth factors is 
rather short (order of minutes), various drug delivery 
systems are being developed to prolong their bio-
availability and control their spatial-temporal release 
profile [11]. 
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The aim of this study was to test platelets in combina-
tion with nanofibers made of FDA-approved biocom-
patible, biodegradable polymers poly-ε-caprolactone 
(PCL) and polyvinyl alcohol (PVA) to improve the 
effect of the released bioactive molecules, and to inves-
tigate if functionalization with platelets could result in 
improved melanocyte proliferation. 
Methods  
Scaffo ld  fabr icat ion & P late let  adhes ion  
The polycaprolactone (PCL) nanofibers were pre-
pared from 24% (w/v) PCL (Sigma-Aldrich, Germany) 
in a mixture of chloroform and ethanol at a ratio of 9:1, 
the polyvinyl alcohol (PVA) nanofibers were prepared 
using 12% (w/v) PVA (Sloviol, Slovakia) with 3% 
(w/v) glyoxal and 1% phosphoric acid as a crosslinking 
agent. The samples were fabricated on a Nanospider™ 
device (Elmarco, Czech Republic) using a wire elec-
trode. The distance between the electrode and the 
collector was 180 mm and the used voltage was 40–
60 kV. 
Samples with a diameter of 6 mm were punched out 
of the nanofibers and sterilized using ethylene oxide at 
37 °C. 
Fresh human leukocyte-poor platelet concentrate 
derived from buffy-coat (in additive solution) was 
obtained from Blood Transfusion Service (Šumperk, 
Czech Republic). The bag was prepared from the blood 
of four donors. The platelet concentration in the bag 
was 1,030×109 platelets/L. In total 50 µL of the platelet 
concentrate was added to the sterile nanofibrous scaf-
folds. The platelets were left to adhere to the scaffolds 
for 2 hours at 22 °C and rinsed with sterile phosphate-
buffered saline. 
Cell  cu lture & Ce l l  seed in g  
The melan-a cell line (normal murine pigmented 
melanocytes) was purchased from the Welcome Trust 
Functional Genomics Cell Bank (St. George’s, Univer-
sity of London). The cells were cultured in DMEM 
supplemented with 10% fetal bovine serum (FBS), 
1% Penicillin/Streptomycin (10,000 IU/mL and 
10,000 µg/ml, respectively), 2 mM L-glutamine and 
200 nM TPA (12-O-Tetradecanoylphorbol-13-acetate) 
at 37 °C in 5% CO2. The cell medium was changed 
every 3 to 4 days. The scaffolds were seeded with me-
lan-a cells at a cell seeding density of 12,500 cells/cm2. 
Scaffo ld  ch aracter izat ion  
The nanofibrous samples were characterized using 
scanning electron microscopy. Samples containing 
platelets were rinsed with PBS and fixed with 2.5% 
glutaraldehyde for four hours at 4 °C. After the fixa-
tion, the samples were dehydrated using ethanol 
changes. Following dehydration, the samples were 
treated with HMDS (Sigma Aldrich, Germany) and 
dried. All of the scanned samples were then fixed to 
a stud and coated with gold (120 s, Quorum Q150RS, 
20 mA). Then, the samples were visualized using 
Vega3 SBU device (Tescan, Czech Republic). 
Metabol ic  act iv ity o f  m elanocytes  
The metabolic activity of melanocytes was deter-
mined using MTS assay (CellTiter 96® AQueous One 
Solution Cell Proliferation Assay, Promega, USA). On 
the experimental days (D1, D3, D6, and D8), 20 µL of 
the MTS substrate was added to 100 µL of fresh media, 
and the scaffolds were incubated at 37 °C for 2 hours. 
Absorbance was detected using an ELISA reader 
(Infinite M200 Pro, Tecan, Switzerland) at 490 nm. 
A wavelength of 690 nm was used as a reference wave-
length. 
Pro li fer at ion of  m elanocytes  
Proliferation of melanocytes was determined using 
a fluorescence kit (Quant-iT™ dsDNA High-Sensi-
tivity Assay Kit, Invitrogen, USA). The samples used 
for the MTS assay were transferred to cell lysis buffer 
(0.2% Triton X-100, 10 mM Tris, 1 mM EDTA) and 
were kept at -80 °C until analysis. Then, the samples 
underwent three freeze-thaw cycles and were pro-
cessed according to the manufacturer’s instructions. 
The fluorescence of the treated samples was read using 
the ELISA plate reader; excitation wavelength was 
485 nm, emission wavelength was 528 nm. 
Visu al izat ion of  ce l l  morphology  
The cells were visualized using confocal micros-
copy. First, the samples were fixed using frozen metha-
nol and stained with DiOC-6 (Life Technologies, USA, 
CA) to visualize cell biological membranes, and pro-
pidium iodide (Sigma-Aldrich, Germany) to visualize 
cell nuclei. The cell area was determined using Ellipse 
software (Ellipse, Slovak Republic) from at least 3 
independent images. Then, to visualize the viability of 
the cells, living cells were stained using BCECF-AM 
(Sigma-Aldrich, Germany) and propidium iodide to 
visualize dead cells. Viable cells metabolized non-
fluorescent BCECF-AM to fluorescent BCECF (green 
color). Propidium iodide does not penetrate into living 
cells, therefore only dead cell had red nuclei. The cells 
were counted using ImageJ software (NIH, USA) from 
at least 3 independent images, the viability of cells is 
expressed as percentage of viable cells of the total 
number of cells present on the scaffolds. The stained 
samples were observed using LSM 510 DUO confocal 
microscope (Zeiss, Germany). DiOC-6 (green color; 
maximum excitation wavelength 484 nm, maximum 
emission wavelength 501 nm), propidium iodide (red 
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color; maximum excitation wavelength 536 nm, maxi-
mum emission wavelength 617 nm), BCECF-AM 
(green color; maximum excitation wavelength 490 nm, 
maximum emission wavelength 535 nm). 
Stat ist ica l  an alys is  
The statistical analysis of the acquired data was 
performed using the SigmaStat 3.5 software (Systat, 
USA). The data were tested using ANOVA and 
Tukey’s test was used for post-hoc analysis. The data 
are presented as mean ± standard deviation. The level 
of significance was set to p<0.05. 
Results  
Nanofibr ous scaf fo ld  ch aracter izat ion  
The fabricated nanofibrous samples were charac-
terized using scanning electron microscopy (Fig. 1). 
The acquired images showed morphology typical for 
PCL and PVA samples with a minimum of spherical 
defects. 
 
Fig. 1: Scanning electron microscopy images of the 
fabricated nanofibrous samples. A – PCL, B – PVA. 
Magnification 10,000×; scale bar 5 µm. 
Throughout the experiment, the presence of platelets 
on the nanofibrous surface was confirmed by scanning 
electron microscopy. According to the obtained 
images, platelets were activated, and a fibrin network 
was formed on the PCL nanofibers (Fig. 2). 
 
Fig. 2: Scanning electron microscopy images of the 
PCL samples functionalized with platelets. Images for 
PVA not shown; no fibrin network was detected. 
A – PCL with platelets and fibrin network, day 1. 
Magnification 4,000×; scale bar 20 µm. B – PCL with 
platelets and fibrin network residua, day 8. Magnifi-
cation 3,000×; scale bar 20 µm. 
Within the network, activated platelets were detected 
on day 1. During the experiment, most of the fibrin 
network was degraded, and on day 8, spherical platelets 
were still detected on the nanofibers surface. No plate-
let adhesion or fibrin network was observed on the 
surface of PVA nanofibers. 
Plate lets  im prove melanocyte adh es ion  
Adhesion of melanocytes to the nanofibrous scaf-
folds was visualized using confocal microscopy 
24 hours after cell seeding (Fig. 3). The acquired 
images were then analyzed using Ellipse software and 
the cell area was determined. 
 
Fig. 3: Melanocyte adhesion to the nanofibers. Adhe-
sion of melanocytes was visualized using confocal 
microscopy on day 1. Cytoplasm is stained with DiOC-
6 (green), nuclei with propidium iodide (red). A – PCL, 
B – PCL/PL, C – PVA, D – PVA/PL. Objective 20×, 
scale bar 100 µm. 
 
Fig. 4: Cell area of melanocytes spread on the nano-
fibrous scaffolds. Level of statistical significance was 
set at p<0.05. 
The acquired images showed melanocytes well 
spread, with either elongated or polygonal morphology 
on the PCL nanofibers, in comparison to the rounded 
or elongated cells detected on the PVA nanofibers. 
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Melanocytes are small cells, therefore the amount of 
cytoplasm and cell spreading area are relatively small. 
Furthermore, the dye used for visualization of bio-
logical membranes (DiOC-6) exhibited non-specific 
binding to the PCL nanofibers, visualizing the nano-
fibrous network. On the PCL/PL and in some extent on 
the PVA/PL samples, biological membranes of plate-
lets adhered to the nanofibrous samples were detected. 
The diameter of platelets is about 2–4 µm, which is 
about 10% of the cell diameter. The data on cell area 
(Fig. 4) showed that functionalization of PCL nano-
fibers with platelets resulted in improved cell spreading 
and indicated favorable cell culture conditions. 
Plate lets  st imu late melanocyte metabol ic  
act iv i ty  
To assess the overall biocompatibility of the scaf-
folds, the nanofibers were seeded with melanocytes 
and the metabolic activity of melanocytes was deter-
mined using the MTS assay (Fig. 5) on days 1, 3, 
6 and 8. 
 
Fig. 5: Metabolic activity of melanocytes seeded on 
nanofibrous scaffolds at a seeding density of 12,500 
cells per cm2 determined on days 1, 3, 6, and 8. The 
statistical significance is given above the graph bars. 
The level of statistical significance was set to p<0.05. 
On the PCL scaffolds (both plain and function-
alized), the metabolic activity of the seeded melano-
cytes was increasing throughout the experiment. The 
functionalization of PCL scaffolds with platelets (PCL/ 
PL) resulted in a statistically significant improvement 
of metabolic activity (p<0.05 on D1; p<0.001 on D3, 
D6, and D8). There was no significant difference in 
metabolic activity detected between the PVA and 
PVA/PL samples. Generally, the metabolic activity of 
melanocytes seeded on the PVA and PVA/PL samples 
was very low, suggesting poor cell culture conditions. 
Plate lets  promote  pro l i ferat ion of  
melanocytes  
The proliferation of melanocytes seeded on the nano-
fibrous scaffolds was detected on the corresponding 
samples on days 1, 3, 6, and 8 (Fig. 6). The acquired 
proliferation data were in concordance with the meta-
bolic activity testing. According to Fig. 6, the PVA 
scaffolds (regardless of platelet functionalization) did 
not promote proliferation of melanocytes. On the plain 
PCL scaffold, an increasing rate of proliferation was 
observed. The functionalization of PCL nanofibers 
with platelets resulted in a statistically significant in-
crease in proliferation of melanocytes on days 3 
(p<0.05), 6, and 8 (p<0.001). 
 
Fig. 6: Proliferation of melanocytes seeded on nano-
fibrous scaffolds at a seeding density of 12,500 cells 
per cm2 determined on days 1, 3, 6, and 8. The statis-
tical significance is given above the graph bars. The 
level of statistical significance was set to p<0.05. 
Viab i l i ty  v isua l izat ion of  melanocytes  
On the last day of the experiment (D8), the melano-
cytes seeded on the nanofibrous scaffolds were visual-
ized using a vital staining. The detected viable cells are 
depicted in green, dead cells in red color (Fig. 7). 
 
Fig.7: Vital staining of melanocytes seeded on the 
nanofibrous scaffolds on day 8. Viable cells are green 
(BCECF-AM), dead cells are red (propidium iodide). 
A – PCL, B – PCL/PL, C – PVA, D – PVA/PL. Magni-
fication 100×, scale bar 200 µm. 
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The scanned images confirmed the data obtained in 
the proliferation and metabolic activity assays. Further-
more, the living and dead cells detected were counted, 
and the obtained data are summarized in Table 1. The 
relative high percentage of viable cells on PVA and 
PVA/PL are caused by the fact that dead cells usually 
detach from the substrate. However, very low numbers 
of living cells (green) were observed on both PVA and 
PVA/PL (Fig. 7). 
Table 1: Summary of viable cells detected on the nano-
fibrous scaffolds. Data were collected from at least 3 
independent images. 
Scaffold Cells/mm2 Viable cells 
 PCL 494 87 
PCL/PL 962 91 
PVA 22 45 
PVA/PL 24 75 
According to the above-mentioned table, the PCL 
scaffolds were a suitable scaffold for melanocyte cul-
ture. The functionalization of the PCL scaffolds with 
platelets lead to an almost 2-fold increase in the cell 
number; the majority of the cells were viable. These 
data are in accordance with the results of MTS and 
proliferation testing. PVA scaffolds did not improve 
cell adhesion and proliferation. Furthermore, more 
non-viable cells were detected on the PVA scaffolds 
when compared to the PCL samples. 
Discussion  
The aim of the study was to test nanofibrous scaf-
folds for prospective use for melanocyte expansion. 
PCL and PVA were chosen as suitable polymers for 
nanofiber production, as they are biocompatible and 
biodegradable. PCL has been shown to support adhe-
sion and proliferation of multiple cell types [12, 13]. 
The fabricated nanofibrous scaffolds were examined 
using scanning electron microscopy and the acquired 
images showed morphology typical for PCL and PVA 
samples. Furthermore, the samples contained a mini-
mum of spherical defects. The stereology of the scaf-
folds was in accordance with other findings [14, 15]. 
The scanning electron microscope also showed a fine 
fibrin network formed on the surface of the platelet-
functionalized samples. During the experiment, the 
morphological changes in activated platelets were 
reversed and spherical platelets were still present on the 
nanofibers by the end of the experiment. These results 
are in accordance with Rampichova et al., who ob-
served platelets present on centrifugally spun PCL 
nanofibers after 14 days of the experiment [16]. No 
platelet adhesion or fibrin network was observed on the 
surface of PVA nanofibers. This is in accordance with 
a very low platelet deposition on PVA nanofibers 
observed by Merkle et al., as PVA lacks cell recog-
nition surface sites [17]. The presence of the fibrin 
network on the PCL nanofibers resulted in improved 
cell spreading in comparison to the PCL control sam-
ple. The influence of the architecture of fibrin fibers on 
cell spreading was investigated by Bruekers et al., who 
found that the denser fiber network promoted the 
spreading of human mesenchymal stem cells [18]. 
The morphology of the cells was studied on day 1. 
The total cell area and the amount of cytoplasm de-
tected were low and corresponded with typical melano-
cyte morphology; elongated or polygonal shape of me-
lanocytes was in agreement with our other experiments 
on PCL nanofibers [19]. It was in contrast to melano-
cyte round or irregular elongated morphology on PVA 
nanofibers which is typical for substrates which do not 
support cell adhesion. 
The confocal images from vital staining do not 
reflect the cell morphology, but clearly reflect cell 
viability as only metabolically active cells metabolize 
the BCECM-AM to green fluorescent dye. However, 
the evaluation of PVA substrates was influenced by 
very low cells attached on the substrates which was 
caused by low proliferation and detachment of dead 
cells and resulted in relatively high cell viability. 
The acquired data are further supported by metabolic 
activity and proliferation findings. According to the 
data, PVA nanofibers are not suitable for cell culture 
regardless of their functionalization with platelets. The 
cell adhesion properties of PVA nanofibers could be 
improved using other polymers, such as chitosan [20], 
gelatin [21] or hyaluronic acid [22]. On the other hand, 
PCL was shown to be effective in fostering the culture 
of melanocyte, which is in accordance with previously 
published data [14, 18]. The suitability of PCL as 
a substrate for melanocyte culture was described by 
Savkovic et al. [23]. They were able to differentiate 
melanocytes from the stem cells of the human hair 
follicle outer root sheath and cultured them on the PCL 
nanofibers. The PCL nanofibers were shown to be su-
perior to the 2D culture environment in terms of mela-
nin production [23]. Functionalization of the nano-
fibers with platelets led to further positive stimulation 
of metabolic activity, viability and proliferation of me-
lanocytes when compared to the plain PCL control. The 
effect may be attributed to the bioactive molecules 
released from the platelets, as there was no statistically 
significant difference between the initial number of 
melanocytes adhered to the PCL and PCL/PL scaffolds 
on day 1 of the experiment, suggesting the fibrin net-
work formed on the surface of the nanofibers improved 
the spreading of melanocytes but not the absolute 
numbers of the seeded cells. 
Possible limitations of the study include inter-
individual platelet variability. The content of bioactive 
substances may be influenced by several characteristics 
of the donors, including their age, sex, platelet count 
and medical conditions [24]. Thus, their effect on cells 
may be variable in different patients. 
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Conclusion  
This study aimed to test nanofibrous scaffolds that 
would support the melanocyte culture for prospective 
use in the treatment of depigmentation disorders. In 
contrary to PVA nanofibers, the PCL nanofibers with 
platelets adhered to the surface of nanofibers and 
represent a promising system. Based on the in vitro 
data, bioactive molecules released from the platelets 
significantly influenced melanocyte behavior. Such 
a facile system delivering a plethora of growth factors 
and other bioactive molecules while enabling autolo-
gous use may be suitable for clinical translation. 
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